We also identified that ACSL3 was aberrantly expressed among genes linked to fatty acid metabolic pathways in NAFLD (Figure 1B), and ASCL3 mRNA levels were upregulated in NASH (Figure 1C). Here, ACSL3 is linked to metabolic dysfunction-associated steatotic liver disease.